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Abstract
Background: The ideal screening test would be capable of identifying iron deficiency in the absence of anemia.
We tried to detect role of urinary hepcidin-25 level in early prediction of iron deficiency in children.
Methods: This is a case control study performed on 100 children in Hematology Unit of Pediatric Department,
Zagazig University Hospital, Egypt. Our study included 25 cases of iron deficiency (ID) stage-1 (iron depletion), 25
cases ID stage-2 (iron-deficient erythropoiesis), 25 cases ID stage-3 (iron deficiency anemia) and 25 healthy children
as a control group. Estimation of iron status parameters was done. Urinary hepcidin-25 level was detected.
Results: Urinary hepcidin-25 level was significantly lower in all stages of iron deficiency than in control group,
more significant reduction in its level was observed with the progress in severity of iron deficiency. Urinary
hepcidin showed significant positive correlation with hemoglobin, mean corpuscular volume, hematocrit value,
serum iron and ferritin and transferrin saturation. In contrary, it showed significant negative correlation with serum
transferrin and total iron binding capacity.
Urinary hepcidin at cutoff point ≤0.94 nmol/mmol Cr could Predict ID stage-1 with sensitivity 88% and specificity
88%. Cutoff point ≤0.42 nmol/mmol Cr could predict ID stage-2 with sensitivity 96% and specificity 92%. Cutoff
point ≤0.08 nmol/mmol Cr could Predict ID stage-3 with Sensitivity 96% and specificity 100%.
Conclusions: We can conclude that detection of urinary hepcidin-25 level was a simple and non invasive test and
could predict iron deficiency very early, before appearance of hematological affections.
Background
Iron deficiency anemia (IDA) affects approximately 30%
of the world’s population with more prevalent in chil-
dren and neonates [1]. IDA in infants and toddlers is
associated with long-lasting diminished mental, motor
and behavioral effects [2]. Treatment with iron leads to
subsequent complete resolution of the anemia and the
iron deficiency (ID). Yet, it does not correct all of the
behavior effects [3]. Furthermore, the lower mental and
motor test scores associated with iron deficiency anemia
persist [2,4].
Three stages of ID may be recognized. The first is
substantial reduction in normal iron stores (iron deple-
tion) [5]. This first stage of ID is often characterized by
low serum ferritin levels [6]. The second stage of ID is a
state of iron-deficient erythropoiesis. In this stage, there
i sas h o r t a g eo fi r o na v a i l a b l et ot h ee r y t h r o i d
precursors in the bone marrow for hemoglobin (Hb)
synthesis [7]. The second stage may be characterized by
abnormalities in particular iron parameters, including
low transferrin saturation (Tsat) levels and elevations in
free erythrocyte zinc protoporphyrin (ZnPP) [6]. The
third and most severe degree of ID involves overt
microcytic anemia due to insufficient iron stores to
maintain red blood cell synthesis, leading to anemia [7].
IDA is characterized by a significant reduction in hemo-
globin level and a decrease in mean corpuscular volume
(MCV) [6].
Additional laboratory findings in IDA include elevated
total iron-binding capacity (TIBC), low Tsat and low
serum iron level [2]. Serum ferritin is the best laboratory
test for the diagnosis of iron deficiency as it may
decrease before a decrease in serum iron level is
detected [8]. It is noteworthy that ferritin level increases
with age. Besides, it is an acute-phase reactant that may
be falsely elevated in the setting of chronic inflamma-
tion, infection, malignancy and chronic renal failure [2].
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another laboratory screening test which is used to assess
iron status. In IDA, there is an increase in zinc transport
across the intestinal membrane to replace the missing
iron in the formation of the protoporphyrin ring [9].
ZnPP assay is a sensitive test; however its specificity
may be limited because ZnPP increases in inflammation,
lead poisoning, anemia of chronic diseases (ACD) and
hemoglobinopathies [10].
Hepcidin is the principal iron-regulatory hormone that
mediates the homeostasis of extracellular iron concen-
trations [11,12]. Hepcidin is initially synthesized as an
84-amino acid preprohepcidin then it is processed in
hepatocytes by a signal peptidase and the prohormone
convertase furin [13] to its bioactive form, 25-amino
acid peptide [14,15]. Hepcidin is produced by hepato-
cytes and is rapidly cleared from the circulation [14].
Urinary hepcidin levels correlate well with hepatic hep-
cidin mRNA [16]. Three hepcidin isoforms (hepcidin-20,
-22 and -25) are excreted in urine. Hepcidin-25 and -20
are also found in serum [14]. Hepcidin-25 is the only
isoform which has a dominant role in iron regulation
[17]. Hepcidin acts by regulating iron influx into plasma
from tissues engaged in iron storage or transport: duo-
denal enterocytes that absorb dietary iron, hepatocytes
that store iron, and macrophages that recycle iron from
senescent erythrocytes. At the molecular level, hepcidin
binds to the sole known cellular iron efflux channel, fer-
roportin, and induces its internalization and lysosomal
degradation by mechanisms similar to those that inacti-
vate other more conventional membrane receptors [18].
N-terminally truncated breakdown products of hepcidin
are detectable in plasma [19] and urine [14,15] but show
impaired ability to internalize ferroportin [20]. Hepcidin
synthesis is physiologically increased by elevated plasma
iron concentration [21,22], decreased by erythropoietic
activity [23] and pathologically increased by inflamma-
tion [21,24]. Hepcidin excess plays the major role in
anemia of inflammation [25]and iron-resistant iron-defi-
ciency anemia [15,26]. At the opposite extreme, hepci-
din deficiency is the cause of iron overload in most
hereditary hemochromatoses [27] and contributes to
iron overload in b-thalassemia and other iron-loading
anemia’s [28]. Urine testing is chosen in preference to
serum assays as (I) it is less affected by diurnal variation,
and (II) the non-invasive nature of sampling [17].
Aim of the work
To detect role of urinary hepcidin-25 level in early pre-
diction of iron deficiency in children.
Methods
This was a case control study performed in Zagazig Uni-
versity Children Hospital and Outpatient Clinics in the
same Hospital from October 2009 to October 2010.
Informed parental consent was obtained to be eligible
for enrollment into the study. The study was done
according to the rules of the Local Ethics Committee of
Faculty of Medicine, Zagazig University. The study
included 75 children presented with ID and 25 healthy
children of comparable age and sex as a control group.
Children were classified as follows:
ID stage-1
25 children presented with normal iron parameters and
hematological parameters except low serum ferritin level
(≤ 20 ng/ml) [6,7,29].
ID stage-2
25 children presented with low serum ferritin (< 12 ng/
ml), low serum Tsat < 16% and increased ZnPP (> 100
ug/dl). Hemoglobin level, MCV and mean corpuscular
hemoglobin concentration (MCHC) were normal for age
[6,29].
ID stage-3
25 children presented with low serum ferritin (< 12 ng/
ml), low Tsat (< 16%), increased ZnPP (> 100 ug/dl)
and picture of microcytic hypochromic anemia (low
hemoglobin level, low MCV and low MCHC) [6,29].
Control group
25 healthy children presented with normal iron para-
meters [29], as serum ferritin level was > 20 ng/ml,
ZnPP level was ≤30 ug/dl and Tsat was > 35%. They
were selected from those who attended Pediatric
Department for preoperative evaluation for elective sur-
gery (eg Hernia, hydrocele and undescended testis).
Samples were collected relatively during a narrow time
period (late morning to early afternoon) and iron levels
were not interpreted in isolation, rather combined with
other iron parameters.
As ferritin, an acute phase reactant, may be elevated
during co-morbid infection(s), we excluded any patient
presented with any evidences of infections or inflamma-
tions [17]. Children were excluded if there were evi-
dences of renal function abnormalities, liver function
abnormalities or history of iron therapy in the previous
three months.
All patients and controls included were subjected to
proper history taking, thorough clinical examination.
Laboratory investigations were done for all studied chil-
dren and included urinalysis, stool analysis, complete
blood count (including blood indices), ESR, C-reactive
protein, liver function and kidney function tests. Iron
parameters (iron, ferritin, transferrin, MCHC, ZnPP,
TIBC and Tsat), creatinine level in urine and urine hep-
cidin-25 level were estimated.
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in whole blood using a fluorometric method, in which
porphyrins and heme components were extracted from
whole blood into an ethyl acetate-acetic acid mixture.
Porphyrins were then separated from heme by back-
extraction into a hydrochloric acid solution, and were
quantitatively determined by molecular fluorometry
using a spectrofluorometer calibrated with protopor-
phyrin IX (PPIX) standard solutions.
Creatinine analysis in urine
Urinary creatinine concentrations were measured by the
Jaffe reaction using the Creatinine Parameter Assay
(R&D Systems, Minneapolis, MN).
Urinary hepcidin analysis
Freshly voided urine samples were collected and 10 mL
aliquots were centrifuged at 5000 rpm for 5 minutes
and frozen at -80°C for batch analyses at the Depart-
ment of Biochemistry, according to the manufacturer’s
protocol; 96-well plates were coated with the antibody
to human hepcidin and incubated with 100 μL (standard
samples) or 200 μL (samples with very low concentra-
tion of hepcidin) of 1:10 dilution of urine in Tris-buf-
fered saline containing 0.05% Tween-20 (TBS-Tween
20), with 10 ng/mL of biotinylated hepcidin-25 (Intrinsic
LifeSciences, La Jolla, CA) added as the tracer. Standard
curves were prepared by serial 2-fold dilution of syn-
thetic hepcidin (Bachem Biosciences, King of Prussia,
PA) 4000 ng/mL in TBS-Tween 20 buffer containing
the tracer. The integrity and bioactivity of synthetic hep-
cidin and biotinylated hepcidin were verified by spectro-
metry and by bioassay [20]. After washing, the assay was
developed with streptavidin-peroxidase and tetramethyl
benzidine. The enzymatic reaction was stopped by sulfu-
ric acid, and the plate was read at 450 nm on a DTX
880 microplate reader (Beckman Coulter, Fullerton,
CA). Standard curves were fitted with 12-point fit using
GraphPad Prism software (GraphPad Software, San
Diego, CA). The fitted curve was then used to convert
sample absorbance readings to hepcidin concentrations.
The intra-assay coefficient of variation (CV) was ranged
from 5-18% and the inter-assay CV was ranged from 3-
14%. The lower limit of detection was 0.07 nmol. To
account for the variable dilution of urine samples, urine
hepcidin concentrations were normalized to urine crea-
tinine (Cr).
Statistical analysis
SPSS for windows, version 11; was used for data analy-
sis. All values were given as mean ± SD. Chi-square
test and ANOVA were used in data analysis. Multiple
comparison analysis by the least significant difference
(LSD) was used to detect statistical difference between
two means when ANOVA test referred to signifi-
cances. The degree of relationship between the vari-
ables was calculated using Pearson correlation analysis
for numerical data and Spearman correlation analysis
for non numerical data. Data had not been trans-
formed as data was normally distributed. Receiver
operating characteristic (ROC) curve analysis was used
to determine the discriminative properties of various
cutoff levels of urinary hepcidin. A value of ≤ 0.05 was
considered significant.
Results
There were no significant differences between patients
and control group as regards age, sex and bodyweight (P
> 0.05) (Table 1). In our results, urinary hepcidin level in
normal healthy control children was 2.8 ± 1.3 nmol/
mmol Cr and the range was 0.62-6.65 nmol/mmol Cr.
Urinary hepcidin levels were significantly lower in all
stages of ID than in control group, more significant
reduction in its level was observed with the progress in
severity of ID (P < 0.01) (Table 1).
Receiver Operating Characteristics (ROC) curve was
used to detect three cutoff points for urinary hepcidin
level to differentiate ID, in its different stages, from
healthy children. Cutoff points differentiating ID (stage-
1, stage-2 and stage-3 respectively) from healthy chil-
dren were ≤0.94, ≤0.42 and ≤0.08 nmol/mmol Cr
respectively. Area under ROC curve was 0.838 (p <
0.001), 0.944 (p < 0.001) and 0.999 (p < 0.001) respec-
tively. 95% confidence interval was (0.707-0.927), (0.840-
0.988) and (0.927-1.000) respectively (Table 2). Sensitiv-
ity of these three cutoff points was 88%, 96% and 96%
respectively. Specificity of these three cutoff points were
88%, 92% and 100% respectively. Positive predictive
v a l u eo ft h e s et h r e ec u t o f fp o i n t sw a s8 8 % ,9 2 . 3 %a n d
100% respectively. Negative predictive value of these
cutoff points were 88%, 95.8% and 96.2% respectively
(Table 2).
Urinary hepcidin cutoff point for detection of ID
stage-1 by ROC curve was demonstrated in Figure 1.
Distribution of ID stage-1 patients and control group
around this cutoff point was shown in Figure 2.
Urinary hepcidin cutoff point for detection of ID
stage-2 by ROC curve was demonstrated in Figure 3.
Distribution of ID stage-2 patients and control group
around this cutoff point was shown in Figure 4.
Urinary hepcidin cutoff point for detection of ID
stage-3 by ROC curve was demonstrated in Figure 5.
Distribution of ID stage- 3 patients and control group
around this cutoff point was shown in Figure 6.
Urinary levels of hepcidin showed significant positive
correlation with Hb, hematocrit value, MCV, MCHC,
serum iron level, ferritin level and Tsat (P < 0.01)
(Table 3). In contrary, urinary levels of hepcidin showed
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and TIBC (P < 0.01) (Table 3).
Discussion
The ideal screening test would be capable of identifying
ID in the absence of anemia. This would help in the
treatment of ID in the pre-anemic stage, preventing IDA
and it’s associated mental, motor and behavior effects.
Such test is not widely used at this time [2].
In our study, urinary hepcidin levels were significantly
lower in all stages of ID than in control group, more sig-
nificant reduction in its level was observed with the pro-
gress in severity of ID. That coincided with Cherian et al
et al [17] who found that urinary hepcidin levels were sig-
nificantly lower in ID and IDA. Hepcidin is homeostati-
cally regulated by iron and erythropoietic activity.
Hepcidin is suppressed in ID, allowing increased absorp-
tion of dietary iron and replenishment of iron stores [15].
The feedback loop between iron and hepcidin ensures
stability of plasma iron concentrations [30]. Hepcidin
production is also regulated by the process which con-
sumes most iron, erythropoiesis [23]. Increased erythro-
poietic activity suppresses hepcidin production which
allows the release of stored iron from macrophages and
hepatocytes, and increased iron absorption, all resulting
in greater supply of iron for hemoglobin synthesis [22].
In our study, we determined three cutoff points for
urinary hepcidin level to differentiate ID in its different
stages (stage-1, stage-2 and stage-3) from healthy chil-
dren. These three cutoff points had strong confidence
intervals and valuable predictive potentials.
Guyatt et al [31] calculated the predictive value and
area under the receiver operating characteristic (ROC)
curve for serum ferritin in detection of IDA. Area under
the receiver operating characteristic (ROC) was 0.95 (p
< 0.001), compared to 0.77 for MCV, 0.74 for transferrin
saturation, and 0.62 for absolute red cell distribution
wideness (RDW).
In our study, urinary hepcidin levels at cutoff point
≤0.08 nmol/mmol Cr could predict ID stage-3 with Sensi-
tivity 96% and specificity 100%. Furthers, urinary hepcidin
levels at cutoff point ≤0.42 nmol/mmol Cr could predict
ID stage-2 with sensitivity 96% and specificity 92%.
There is a shortage of iron available to the erythroid
precursors in the bone marrow for hemoglobin synthesis
Table 1 Clinical and laboratory data in patients and controls
Control
(n = 25)
(Stage-1 ID) (n = 25) (Stage-2 ID) (n = 25) (Stage-3 ID) (n = 25) P
Age (year) 5.0 ± 0.9 5.1 ± 1.2 5.2 ± 1.3 4.9 ± 1.2 > 0.05
Male/female * 14/11 14/11 13/12 14/11 > 0.05
Body weight (kg) 17.2 ± 2.2 16.7 ± 2.3 16.0 ± 3.1 16.4 ± 2.6 > 0.05
Hb (g/dl) 12.5 ± 0.6
a 11.9 ± 1.1
a 11.8 ± 1.2
a 7.9 ± 1.2
b < 0.05
Hematocrit (%) 37.6 ± 2.1
a 35.8 ± 2.4
a 35.5 ± 1.5
a 23.6 ± 2.1
b < 0.05
MCV (fl) 92.3 ± 7.0
a 87.8 ± 5.1
a 86.8 ± 4.6
a 61.1 ± 3.1
b < 0.05
MCHC (%) 34.1 ± 2.6
a 34.0 ± 2.1
a 33.9 ± 2.3
a 26.1 ± 2.4
b < 0.05
Serum iron (ug/dl) 95.1 ± 4.6
a 89.8 ± 2.5
a 55.8 ± 2.5
b 20.6 ± 1.1
c < 0.05
TIBC(mg/dl) 264 ± 15
a 254 ± 34
a 391 ± 24
b 483 ± 21
c < 0.05
Tsat (%) 36.0 ± 1.1
a 35.4 ± 0.6
a 14.3 ± 0.9
b 4.3 ± 0.6
c < 0.05
Transferrin (umol/L) 34 ± 2.3
a 36 ± 2.5
a 35 ± 3.4
a 76.2 ± 13.6
b < 0.05
Ferritin (ng/ml) 69.2 ± 4.1
a 16.0 ± 1.6
b 10.5 ± 1.3
c 5.3 ± 1.1
d < 0.05
ZnPP (ug/dl) 27 ± 1.3
a 28 ± 2.3
a 129 ± 10.1
b 134 ± 12.3
b < 0.01
Urinary hepcidin-25 (nmol/mmol Cr) 2.8 ± 1.3
a 0.7 ± 0.22
b 0.3 ± 0.09
c .079 ± .009
d < 0.01
The P value is for the difference between all groups by ANOVA test. aa, bb = non-significant (p > 0.05). ab, ac, ad = significant (P < 0.05). bc, bd, cd = significant
(P < 0.05). *Chi-square test. Tsat = Transferrin saturation, ZnPP = erythrocyte zinc protoporphyrin.
Table 2 Predictive values of urinary hepcidin level in
detection of iron deficiency
Urinary hepcidin-25 level for
detection of
Stage-1
(ID)
Stage-2
(ID)
Stage-3
(IDA)
Area under ROC curve 0.838 0.944 0.999
Standard error 0.058 0.034 0.004
95%confidence interval 0.707-0.927 0.840-0.988 0.927-1.000
Significance level p
(area = 0.05)
0.0001 0.0001 0.0001
Cut off point
(nmol/mmol Cr)
≤ 0.94 ≤ 0.42 ≤ 0.08
Sensitivity (%) 88.0 96.0 96.0
Specificity (%) 88.0 92.0 100.0
Positive predictive value (%) 88.0 92.3 100
Negative predictive value (%) 88.0 95.8 96.2
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characterized by abnormalities in particular iron para-
meters, including low Tsat and elevation in ZnPP level.
Hemoglobin levels may be reduced but the resulting
mild anemia may not be detectable using normal cutoff
values for hemoglobin. Iron deficient erythropoiesis may
be undetectable by using traditional laboratory para-
meters. In iron deficient erythropoiesis (second stage
ID), storage iron may be normal or even increased due
to impaired release of iron into the circulation [6].
In our study, urinary hepcidin levels at cutoff point
≤0.94 nmol/mmol Cr could predict ID stage-1 with sen-
sitivity 88% and specificity 88%.
Beutler et al [5] stated that there is no overt effect
on erythropoiesis in the first stage of ID; blood hemo-
globin levels are usually normal, and ID generally can
escape detection by hemoglobin or hematocrit screen-
ing. We obtained these relatively low values due to
presence of three false positive cases and three false
negative cases at the cutoff level ≤0.94 nmol/mmol Cr.
We could not exactly explain if this result was due to
fallacies in ferritin assay, which might be associated
with missed cases (false negative) in control group and
over estimation (false positive) in ID stage-1 group, or
it might be related to limitation in hepcidin at this
relatively high (≤0.94 nmol/mmol Cr) cutoff level. An
Figure 1 Determination of hepcidin cutoff level for ID stage- 1.
Figure 2 Distribution of ID stage- 1 patients and controls around the cutoff point.
Figure 3 Determination of hepcidin cutoff level for ID stage- 2.
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dation of Kis et al [32] in a retrospective study of 101
patients, who had undergone bone marrow aspiration,
as they found that a ferritin of ≤100 μg/l had 64.9%
sensitivity and 96.1% specificity for IDA. It is note-
worthy that ferritin level increases with age, and is an
acute-phase reactant that may be falsely elevated in the
setting of chronic inflammation, infection, malignancy
and chronic renal failure [23,31]. In this situation, per-
forming bone marrow aspiration may provide more
explanation about this finding through estimation of
stainable tissue iron.
In our study, urinary levels of hepcidin showed signifi-
cant positive correlation with Hb, MCV, MCHC, hema-
tocrit value, serum iron level, ferritin level and Tsat (P <
0.01). On the other hand urinary levels of hepcidin
showed significant negative correlation with serum
transferrin and TIBC (P < 0.01).
That agreed with the study which carried by Cherian
et al [17], they demonstrated that hepcidin was posi-
tively associated with hemoglobin, MCV, iron, ferritin
Figure 4 Distribution of ID stage- 2 patients and controls around the cutoff point.
Figure 5 Determination of hepcidin cutoff level for ID stage- 3.
Figure 6 Distribution of ID stage- 3 patients and controls around the cutoff point.
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associated with transferrin.
O n eo fo u rl i m i t a t i o n si nt h i ss t u d yw a st h es m a l l
number of cases as we tried to select demographic
matched groups. To the best of our knowledge, this was
the first trial to determine cutoff level for hepcidin in
diagnosis of iron deficiency.
Conclusions
Detection of urinary hepcidin-25 level was a simple and
non invasive test and could predict iron deficiency very
early, before appearance of hematological affection.
These findings raise the issue as to whether it would
be beneficial to recommend urine hepcidin as a preli-
minary qualifying test for detection of very early iron
deficiency in children and blood donors. A wider and
larger multicenter prospective study will be necessary to
confirm these findings in other populations.
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